However, we do not know the detailed molecular mechanism yet and future research in this direction will provide new mechanistic information to understand oncogenic PKCζ-NFκB-p65 signaling and to develop potential therapeutic strategy for breast cancer. The gene discussed is NFKB1; the disease is breast carcinoma.